{"schema_version":"1","generated_at":"2026-10-28T02:59:20.497Z","data_as_of":"2026-10-25","url":"https://www.findmykol.com/kol/margot-lazow","json_url":"https://www.findmykol.com/kol/margot-lazow/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"margot-lazow","name":"Margot Lazow","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Neuro-Oncology","therapeutic_areas":["Neuro-Oncology","Leukemia"],"institution":"Nationwide Children's Hospital","institution_url":"https://www.findmykol.com/institution/nationwide-children-s-hospital","city":"Columbus","state":"OH","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1952797664","orcid":"0000-0003-4362-4270","openalex":"A5050569696"},"summary":"Margot Lazow is a Glioma Diagnosis and Treatment physician affiliated with Nationwide Children's Hospital. OpenAlex indexes 85 publications with 1,120 citations (h-index 15); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.","overview":{"text":"Margot Lazow, M.D., is affiliated with Nationwide Children's Hospital. The public record shows 85 publications with 1,120 citations (h-index 15), centered on Glioma Diagnosis and Treatment, Acute Lymphoblastic Leukemia research, Cancer Genomics and Diagnostics. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 1 companies, 2 NIH-funded awards (2022–2025).","bullets":["Most recent indexed publication: 2025 · Cancers","Top research focus: Glioma Diagnosis and Treatment","5 registered trials on ClinicalTrials.gov","Open Payments reporting from 1 companies"],"generated_at":"2026-10-27"},"focus":{"indications":[{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":5,"topics":1,"strength":16},{"label":"Glioma","therapeutic_area":"Oncology","trials":5,"topics":0,"strength":15},{"label":"Diffuse Intrinsic Pontine Glioma","therapeutic_area":"Oncology","trials":5,"topics":0,"strength":15},{"label":"Astrocytoma","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Central Nervous System Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Medulloblastoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Meningioma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Ependymoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Leukemia (AML/ALL/CML/CLL)","therapeutic_area":"Oncology","trials":0,"topics":1,"strength":1},{"label":"Macular Degeneration (AMD)","therapeutic_area":"Ophthalmology","trials":0,"topics":1,"strength":1}],"research_topics":["Glioma Diagnosis and Treatment","Acute Lymphoblastic Leukemia research","Cancer Genomics and Diagnostics","Chromatin Remodeling and Cancer","Retinal Diseases and Treatments"],"drugs_studied":{"total":1,"shown":1,"withheld":0,"rows":[{"name":"Ojemda","generic":"Tovorafenib","trials":0,"payments":1,"publications":0,"mentions":1}]},"works_with":{"total":3,"shown":3,"withheld":0,"rows":[{"name":"Nationwide Children's Hospital","trials":4,"payments":0,"mentions":4},{"name":"Day One Biopharmaceuticals","trials":0,"payments":1,"mentions":1},{"name":"University of California, San Francisco","trials":1,"payments":0,"mentions":1}]}},"scholarship":{"works_count":85,"cited_by_count":1120,"h_index":15,"i10_index":21,"pubmed_count":6,"latest_activity_year":2025,"source":"works"},"trials":{"count":5,"shown":3,"withheld":2,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT05843253","title":"Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant","phase":"PHASE2","status":"RECRUITING","role":"Investigator","sponsor":"Nationwide Children's Hospital","source_url":"https://clinicaltrials.gov/study/NCT05843253","trial_url":"https://www.findmykol.com/trial/NCT05843253"},{"nct":"NCT05839379","title":"Targeted Pediatric High-Grade Glioma Therapy","status":"RECRUITING","role":"Investigator","sponsor":"Nationwide Children's Hospital","source_url":"https://clinicaltrials.gov/study/NCT05839379","trial_url":"https://www.findmykol.com/trial/NCT05839379"},{"nct":"NCT05278208","title":"Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors","phase":"PHASE1/PHASE2","status":"RECRUITING","role":"Investigator","sponsor":"Nationwide Children's Hospital","source_url":"https://clinicaltrials.gov/study/NCT05278208","trial_url":"https://www.findmykol.com/trial/NCT05278208"}],"source":"trials"},"payments":{"company_count":1,"program_years":{"first":2025,"last":2025},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"Day One Biopharmaceuticals","program_year":2025,"amount_usd":3107.5,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1952797664"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1952797664","source":"payments"},"funding":{"award_count":2,"fiscal_years":{"first":2022,"last":2025},"rows_total":3,"shown":3,"withheld":0,"rows":[{"project":"R01FD008167","title":"Phase II, Multi-arm, Molecularly-Guided Umbrella Trial for Children and Young Adults with High-Grade Glioma","fiscal_year":2025,"amount_usd":3218733,"organization":"RESEARCH INST NATIONWIDE CHILDREN'S HOSP","source_url":"https://reporter.nih.gov/quickSearch/R01FD008167"},{"project":"R01FD007532","title":"Phase I/II Study of 177Lu-DOTATATE in Children and Young Adults with Recurrent/Progressive High-Grade CNS Tumors and Meningiomas which Express Somatostatin Type 2A Receptors [9/24/21 IND]","fiscal_year":2024,"amount_usd":485894,"organization":"RESEARCH INST NATIONWIDE CHILDREN'S HOSP","source_url":"https://reporter.nih.gov/quickSearch/R01FD007532"},{"project":"R01FD007532","title":"Phase I/II Study of 177Lu-DOTATATE in Children and Young Adults with Recurrent/Progressive High-Grade CNS Tumors and Meningiomas which Express Somatostatin Type 2A Receptors [9/24/21 IND]","fiscal_year":2022,"amount_usd":784837,"organization":"RESEARCH INST NATIONWIDE CHILDREN'S HOSP","source_url":"https://reporter.nih.gov/quickSearch/R01FD007532"}],"source":"grants"},"congress":{"count":2,"years":{"first":2022,"last":2025},"societies":["ASCO","ASTRO"],"shown":2,"withheld":0,"rows":[{"title":"A phase 1 study to evaluate the safety and tolerability of BXQ-350, a novel sphingolipid metabolism modulator, in pediatric diffuse intrinsic pontine glioma and diffuse midline glioma.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2025,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2025.43.16_suppl.e14044","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.e14044","status":"verified"},{"title":"Risk of Secondary Malignant Neoplasms in Children Following Proton Therapy vs. Photon Therapy for Primary CNS Tumors","society":"ASTRO","meeting":"ASTRO Annual Meeting","year":2022,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1016/j.ijrobp.2022.07.1757","source_url":"https://doi.org/10.1016/j.ijrobp.2022.07.1757","status":"verified"}],"source":"congress"},"publications":{"total":6,"shown":5,"withheld":1,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Treating Pediatric Oncology Patients: The Emerging Role of Radioligand Therapy.","year":2025,"journal":"Cancers","types":["Journal Article","Review"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41375023/","status":"verified"},{"title":"Comprehensive Genomic Characterization of Congenital and Infantile Cancers Reveals High Yield of Medically Meaningful Findings.","year":2025,"journal":"JCO precision oncology","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/40479623/","status":"verified"},{"title":"Volumetric endpoints in diffuse intrinsic pontine glioma: comparison to cross-sectional measures and outcome correlations in the International DIPG/DMG Registry.","year":2022,"journal":"Neuro-oncology","types":["Journal Article","Research Support, Non-U.S. Gov't"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/35148393/","status":"verified"},{"title":"Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry.","year":2022,"journal":"Neuro-oncology","types":["Journal Article","Research Support, Non-U.S. Gov't"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/34668975/","status":"verified"},{"title":"Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report.","year":2022,"journal":"Neuro-oncology advances","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/35611273/","status":"verified"}],"most_cited":{"total":85,"shown":5,"withheld":80,"rows":[{"title":"Thickness of Receptor and Post-receptor Retinal Layers in Patients with Retinitis Pigmentosa Measured with Frequency-Domain Optical Coherence Tomography","year":2009,"cited_by_count":209,"type":"article","source_url":"https://doi.org/10.1167/iovs.08-2936"},{"title":"The Transition Zone between Healthy and Diseased Retina in Patients with Retinitis Pigmentosa","year":2010,"cited_by_count":160,"type":"article","source_url":"https://doi.org/10.1167/iovs.10-5799"},{"title":"Method for deriving visual field boundaries from OCT scans of patients with retinitis pigmentosa","year":2011,"cited_by_count":101,"type":"article","source_url":"https://doi.org/10.1364/boe.2.001106"},{"title":"Transition Zones between Healthy and Diseased Retina in Choroideremia (CHM) and Stargardt Disease (STGD) as Compared to Retinitis Pigmentosa (RP)","year":2011,"cited_by_count":70,"type":"article","source_url":"https://doi.org/10.1167/iovs.11-8554"},{"title":"Medulloblastoma in the Modern Era: Review of Contemporary Trials, Molecular Advances, and Updates in Management","year":2022,"cited_by_count":55,"type":"article","source_url":"https://doi.org/10.1007/s13311-022-01273-0"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Maryam Fouladi","coauthored_works":47,"profile_url":"https://www.findmykol.com/kol/maryam-fouladi"},{"name":"Ralph Salloum","coauthored_works":27,"profile_url":"https://www.findmykol.com/kol/ralph-salloum"},{"name":"Rachid Drissi","coauthored_works":22}],"source":"works"},"presence":{"mentions":{"total":1,"shown":1,"rows":[{"url":"https://pnoc.us/?p=962","platform":"other","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"similar":[{"name":"Maryam Fouladi","slug":"maryam-fouladi","institution":"Nationwide Children's Hospital","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/maryam-fouladi","json_url":"https://www.findmykol.com/kol/maryam-fouladi/profile.json"},{"name":"Toshiharu Shinoka","slug":"toshiharu-shinoka","institution":"Nationwide Children's Hospital","specialty":"Thoracic Surgery (Cardiothoracic Vascular Surgery)","url":"https://www.findmykol.com/kol/toshiharu-shinoka","json_url":"https://www.findmykol.com/kol/toshiharu-shinoka/profile.json"},{"name":"William Smoyer","slug":"william-smoyer","institution":"Nationwide Children's Hospital","specialty":"Pediatric Nephrology","url":"https://www.findmykol.com/kol/william-smoyer","json_url":"https://www.findmykol.com/kol/william-smoyer/profile.json"},{"name":"Mark Galantowicz","slug":"mark-galantowicz","institution":"Nationwide Children's Hospital","specialty":"Thoracic Surgery (Cardiothoracic Vascular Surgery)","url":"https://www.findmykol.com/kol/mark-galantowicz","json_url":"https://www.findmykol.com/kol/mark-galantowicz/profile.json"},{"name":"Guy McKhann","slug":"guy-mckhann","institution":"Emory University School of Medicine","specialty":"Neurological Surgery","url":"https://www.findmykol.com/kol/guy-mckhann","json_url":"https://www.findmykol.com/kol/guy-mckhann/profile.json"},{"name":"Patrick Wen","slug":"patrick-wen","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/patrick-wen","json_url":"https://www.findmykol.com/kol/patrick-wen/profile.json"},{"name":"Minesh Mehta","slug":"minesh-mehta","institution":"Florida International University Herbert Wertheim College of Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/minesh-mehta","json_url":"https://www.findmykol.com/kol/minesh-mehta/profile.json"},{"name":"Timothy Cloughesy","slug":"timothy-cloughesy","institution":"Ronald Reagan UCLA Medical Center","specialty":"Neurology","url":"https://www.findmykol.com/kol/timothy-cloughesy","json_url":"https://www.findmykol.com/kol/timothy-cloughesy/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":2,"publications":1,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-26"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-10-26"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2025 to 2025","collected_at":"2026-10-26"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year","collected_at":"2026-10-26"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-10-26"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-10-26"}},"methodology_url":"https://www.findmykol.com/about#methodology"}